Enhanced Detection of Adverse Glycemic Events in Hospital with Unmasked Continuous Glucose Monitoring Versus Point-of-Care Testing in People with Type 1 Diabetes
{{output}}
Background: In people with type 1 diabetes (T1D) admitted to hospital, adverse glycemic events (AGE), both hypoglycemia and hyperglycemia, bestow risk for adverse outcomes. Continuous glucose monitoring (CGM) use is increasingly ... ...
